┌──────────────────────────────────────────────────────────────┐ RECORD TYPE ......... SUBJECT FILE SUBJECT TYPE ........ ORG FILE OPENED ......... 2026-07-05 17:23 UTC APPEARANCES ......... 2 ANNOTATIONS KNOWN ALIASES ....... 1 └──────────────────────────────────────────────────────────────┘
The BMJ
ALSO APPEARS AS
- BMJ
APPEARS IN THE MARGINS OF
- Study 329 Ghostwriting: Prior Disclosure in Review Boards or Journals
Study 329 was a clinical trial of the antidepressant paroxetine (Paxil) for adolescents with major depressive disorder, conducted by SmithKline Beecham (later GlaxoSmithKline) from 1994 to 1998. The o…
- Major Medical Journals' Citation of Study 329 in Policy Changes
The clinical trial known as Study 329, which investigated the efficacy of paroxetine in adolescents with major depressive disorder, was conducted from 1994 to 1998 and published in 2001 (Source 6). Th…